NEWS AND UPDATES
Filmmakers Launch Kickstarter Campaign for Michele Baldwin Documentary
2014 Training Workshop Invitation
2014 Second Quarter Report
2014 First Quarter Report
November 2013 Training Workshop
VISIT OUR PARENT ORGANIZATION
VISIT OUR SISTER SITE

Who We Are

The Global Initiative Against HPV and Cervical Cancer (GIAHC), a program of the American Sexual Health Association, aims to empower people, communities and societies internationally to reduce the disease burden from HPV and cervical cancers through collective engagement, advocacy, collaboration and education.


Shobha S. Krishnan, MD, President and Founder of GIAHC

Shobha Krishnan

Shobha S. Krishnan, MD, is a board certified family physician and gynecologist. She has been involved in the areas of primary care and women's health for over 25 years. She has extensive experience both nationally and internationally in the field of HPV and HPV related diseases. Her vast experience and expertise in this field have given her a unique perspective on the various issues related to HPV and its disease consequences.

Dr. Krishnan is a member on the expert's panel of the American Sexual Health Association, Medical Advisory Board of the National Cervical Cancer Coalition and serves on the scientific advisory committee of the Akbaraly foundation based in Madagascar. She has also served as a member of the STD research-working group at the Columbia College of Physicians and Surgeons and as surveillance physician for the Centers for Disease Control and Prevention.

She is the author of the award-winning book, The HPV Vaccine Controversy: Sex, Cancer, God and Politics. The book is the recipient of the 2009 Book of the Year Award from the American Journal of Nursing and is the winner of two 2010 International Book Awards. Details of the book and other pertinent information can be found at thehpvbook.com.

GIAHC Board of Directors

Mr. Venkat Sadasivan
Senior Finance Director, Dow Chemicals, Houston, Texas
Chairman

Venkat Sadasivan is a senior finance director with the Dow Chemical Company. He has extensive financial background in comptrollers, treasury and business finance. In 1999, he was appointed as the Chief Financial Officer and Controller for Dow Thailand and Vietnam operations. He has served on the board of various joint venture companies and as a member of the tax and legal committee with the American Chamber of Commerce.

He has had first hand experience in taking care of family members with cancer and has a deep understanding of GIAHC’s objectives to fulfill its mission.

 

Ms. Lynn Barclay
President and CEO of American Sexual Health Association.

Lynn Barclay

Lynn Barclay is the President and CEO of the American Sexual Health Association. Ms. Barclay has been in this position since July 2005 and is responsible for overall management of ASHA including its wholly owned for profit, Empatha, Inc. She has supervised the expansion of ASHAs constituents from less than 100 to more than 8,000.

Prior to joining ASHA, she held several leadership and management positions at various organizations including the Funding Center at Washington D.C and at the United Way of America, Alexandria, Virginia. Ms. Barclay brings with her extensive knowledge in HPV and cervical cancer prevention programs.

 

 

Ms. Cinzia Akbarlay
Founder and President of Akbaraly Foundation, Madagascar, Africa

Cinzia Akbaraly, is an Italian-educated economist who specializes in the welfare of developing countries. After meeting her husband, Ylias Akbaraly, she moved to Madagascar in 1993. In 2000, she was appointed the General Consul for Italy in Madagascar. In 1994, she founded the Fihavanana Association, an organization to help orphanages and poor kids of Madagascar. In 2008, she and her husband founded the Akbaraly Foundation and started the 4AWOMAN project, helping women to prevent and treat cancer in Madagascar, supported by the World Health Organization. In 2011, she organized the TedX Antananarivo event “Ideas for Women Cancer Control In Africa”. The Akbaraly Foundation has additional offices in Italy, India and the USA. It strives to improve the welfare of the needy by increasing their access to basic human needs like drinking water, food, medical help, building houses and schools. Cinzia's own personal journey with cancer and her dedication to supporting cancer prevention programs gives her tremendous insight to GIAHCs mission.

 

Shobha S. Krishnan, M.D
Founder and President of GIAHC, New York, New York

GIAHC Advisory Committee

Dr. Jerome Belinson

Jerome L Belinson, MD, is the President and founder of Preventive Oncology International, Inc., a research organization that blends humanitarian work with investigative science. Dr. Belinson has worked for more than 14 years in rural China in multiple provinces throughout the country. His initial study known as SPOCCS I, The Shanxi Province Cervical Cancer Screening Study, received international acclaim and it continues to serve as a model for study design in epidemiology courses around the world. This study provided the true sensitivity and specificity of multiple screening technologies. The work of Dr. Belinson and his P.O.I. colleagues has also been recognized for their careful adherence to human values and the proper conduct of studies involving humans in the developing world. In addition to China, POI has conducted studies in the Dominican Republic, Mexico, and the US.

Dr. Belinson is the Ex-officio Chairman of the Department of Obstetrics and Gynecology at the Cleveland Clinic Foundation 1990-2000. He has dedicated his career to advancing the screening and treatment of gynecologic cancers. He received the 2004 distinguished graduate Citation of Merit from the University of Missouri Medical School, The Bruce Hubbard Stewart award for humanitarianism in medicine at the Cleveland Clinic, and has been consistently listed among the "Best Doctors in America". In 2010 Dr Belinson received the "Chinese Friendship Award", the highest recognition China gives to a foreigner.

Dr. Bellison has served as an advisor to the Ministry of Science in India, the medical advisory board for the Gates Foundation START project (to develop a rapid low cost HPV test), and serves on the Board of Directors of Grounds for Health, an organization that provides care for women in the coffee growing regions of the world.

 

Mrs. Sushma Iyengar

Mrs. Sushma Iyengar is the founder of Kutch Mahila Vikas Sangathan (KVMS), an organization of rural women in Gujarat, India, dedicated to empowering women to increase their income in a sustainable way. Today the members of KVMS provide leadership to over 14,000 women and communities in 175 villages. Its collectives focus on issues of ecological restoration and adaptation to drought, strengthening women’s roles and resource access in their traditional economies of animal husbandry and embroidered craft, domestic violence, reproductive health, land tenancy rights and political participation. The collective has pioneered the use of community radio in the country.

As the Coordinating Head of the KMVS network, Iyengar led the relief and rehabilitation coordination following the 2001 earthquake in the region. Iyengar’s work brought several awards and recognition. In 1996 she received the Gondhia Award for Social Work. She was nominated in 2005 by India Today as one of the 30 young, powerful women influencers in the country, and in 2007 was featured on CNN-IBN in its series on individuals who have contributed to India’s development.

 

Mathuram Santosham, MD

Mathuram Santosham, MD, is the Program Director for Health Systems at the Johns Hopkins University (JHU) Bloomberg School of Public Health in Baltimore, Maryland. He is also the Director of the Center for American Indian and Alaskan Native Health, and a Professor in the Department of International Health, and the Department of Pediatrics at JHU.

Dr. Santosham is internationally known for his work on childhood vaccines and oral rehydration therapy. Dr. Santosham serves on numerous national and international committees on infant vaccines. He has acted as consultant for several international agencies including WHO, USAID and UNICEF. He is the author of over 100 peer-reviewed journals and serves as a reviewer for several international medical journals. He is the recipient of numerous awards including the prestigious Thrasher Research Fund award for excellence in research.

 

Madelon Lubin Finkel, PhD

Madelon Lubin Finkel, PhD, presently holds the rank of Professor of Clinical Public Health as well as Course Director for the Department (Epidemiology, Biostatistics, Evidence-Based Medicine, Introduction to the Health Care System, and Clinical Clerkship in Health Care Policy) at Cornell Medical College, New York. In addition to her faculty appointment at Cornell Medical College, Dr. Finkel also holds the rank of Professor of Research in Medicine at SUNY Stony Brook, and was a Visiting Professor at the School of Public Health, University of Sydney (Australia) in 2004. In 2008, she was named a Fulbright Senior Specialist awarded by The Fulbright Program, sponsored by the U.S. Department of State’s Bureau of Educational and Cultural Affairs. The Program promotes linkages between U.S. academics and professionals and their counterparts at universities abroad.

Women's health issues have been the focus of past and present research projects. She is now working on a cervical cancer screening and HPV project in rural India. Dr. Finkel has been involved in epidemiological research and healthcare policy studies. She has published numerous articles in the area of health care cost management. Other research activities focus on pharmaco-epidemiology, women’s health, and quality assurance. Dr. Finkel's 9th book (on mammography screening) was published in 2005, and her 10th book, Truth, Lies, and Public Health: How We Are Affected when Science and Politics Collide was published in 2007. She served as Editor on a three-volume text on public health, Public Health in the 21st Century (Praeger Publishing, 2011)

Dr. Finkel has served as consultant to numerous organizations, including law firms and pharmaceutical companies, in the areas of epidemiology and health care policy. She has been appointed by the Director General of the WHO to the WHO Expert Advisory Panel on Drug Evaluation. She is a member of the American College of Epidemiology, an advisor to the American Council on Science and Health, and a charter member of the Academy of Benefit Authors of the International Foundation of Employee Benefit Plans.

Teaching and writing are very important. Dr Finkel has twice been awarded the highest teaching honor at Cornell Medical College, the Excellence in Teaching Award, which is bestowed to those professors who are nominated and elected by students and the administration.

 

Anna Guiliano, PhD

Anna Guiliano, PhD, is Chair of the Department of Epidemiology and Genetics, and Program Leader of the Risk Assessment, Detection, and Intervention Program at the Moffitt Cancer in Tampa, Florida. Dr. Giuliano is a consultant for several large NIH-funded cervical cancer prevention programs, and she serves as an advisory board member to several large international research consortia.

She is the recipient of several large grants from the NIH, the National Cancer Institute, and the Centers for Disease Control and Prevention for research on HPV infection among women and men, with a specific interest in prevention interventions such as those promoting cervical cancer screening among underserved women in the US and in Latin America and vaccine prevention strategies. Other areas of research interest include understanding the factors that allow HPV infection to progress to disease among women and men, HPV and its association with non-melanoma skin, and other viral associated cancers such as Merkel Cell Carcinoma.

Dr. Giuliano serves as a reviewer for several NIH grant review panels and as manuscript reviewer for several journals, including the Journal of the National Cancer Institute, International Journal of Cancer, Journal of Infectious Diseases, and JAMA. She has published over 160 original scientific manuscripts in peer-reviewed journals such as Lancet Oncology, Cancer Epidemiology Biomarkers and Prevention, Journal of the National Cancer Institute, and the International Journal of Cancer. Dr. Giuliano contributed significantly to the 1999 Institute of Medicine (IOM) report The Unequal Burden of Cancer and to the WHO IARC HPV Monograph published in 2007.

 

Surbhi Grover, MD, MPH

Surbhi Grover, MD, MPH, is a final year resident in the Department of Radiation Oncology at the University of Pennsylvania and will be joining the faculty in the department of radiation oncology as assistant professor in July 2014. She graduated magna cum laude from Columbia University in 2004, where she earned her BA in development economics. Subsequently, she attended Harvard Medical School and earned her MD in 2009. She completed her internal medicine internship at the University of Pennsylvania in 2009 and started her residency in radiation oncology in 2010. She completed her Masters in Public Health at Johns Hopkins University in 2013 and was the recipient of the Sommer scholarship for Global Health Leadership award.

She is interested in addressing the growing global cancer burden by focusing on public health endeavors and cost-effective clinical initiatives to improve access to care and outcomes of care in developing countries. Her research interests include racial and ethnic disparities in cancer care and outcomes, HIV-related malignancies, implementation and up scaling of prevention and treatment programs in low resource settings. Before starting her residency she worked with Prof. Jeffrey Sachs at the Earth Institute and the Gates Foundation on advising the Ministry of Health of India on the National Rural Health Mission, a rural health initiative to strengthen basic and preventive healthcare in rural India. Since 2011 she has been working with the Botswana-UPENN partnership in developing an oncology program in Botswana. She is especially interested in doing research focusing on epidemiology of HPV related cancers (cervical, head and neck and anal) and treatment outcomes in patients with HIV and malignancies.

Dr. Grover is a member of the Indian Working Group for the ASTRO international education subcommittee. She has worked with GIAHC since its inception in 2009 and has spent time on its program sites as an intern and has been an active contributor to its development.

GIAHC Ambassador

Alan Kaye

Mr. Kaye has been involved in cancer diagnostics advocacy since 1996 when he co-founded the National Cervical Cancer Coalition (NCCC) with his late wife, Randi. The NCCC has local chapters throughout the United States. Alan is also working with the Global Initiative Against HPV and Cervical Cancer (GIAHC) to spread awareness about cervical cancer and HPV (human papilloma virus that causes 99% of cervical cancers and many other cancers) globally.

For 12 years, Mr. Kaye was the co-owner of a national molecular/pathology laboratory and had 37 years experience in laboratory medicine prior to his retirement. In addition to NCCC, he participated in the Listen & Learn program with the American Association Cancer Research (AACR), the Gynecologic Cancer Foundation (GCF), and served at the National Cancer Institute (NCI) for seven years as a healthcare cancer advocate on the DCLG & the DSMB.

Mr. Kaye has helped pioneer community efforts to increase cervical cancer awareness and human papillomavirus (HPV) education. Along with others, he successfully worked to designate January as Cervical Health Awareness Month and for more than two decades has been active in grassroots campaigns to promote awareness year-round as well as during Cervical Health Awareness Month. As the past executive director of NCCC, he testified before the FDA on new technologies and was a member of the advocate planning group for a national conference held in Washington, DC on the cervical cancer/HPV vaccine. He is currently a member of the board of directors of the American Sexual Health Association (ASHA).

Mr. Kaye is a registered yoga teacher and is focused in on therapeutic yoga and enhancing yoga into the emerging integrative medicine model to help enhance patient outcomes and improve quality of life for the patient.